Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A performance evaluation study: Variant annotation tools - the enigma of clinical next generation sequencing (NGS) based genetic testing. | J Pathol Inform | 2022 | 36268089 | PubTator, text mining | PubMed |
| Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36263323 | PubTator, text mining | PubMed |
| Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung Adenocarcinoma. | J Oncol | 2022 | 36262349 | PubTator, text mining | PubMed |
| Does plantar skin abrasion affect cutaneous mechanosensation? | Physiol Rep | 2022 | 36259120 | PubTator, text mining | PubMed |
| A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes. | Nat Cancer | 2022 | 36253484 | PubTator, text mining | PubMed |
| Nutritional Composition and Estimated Iron and Zinc Bioavailability of Meat Substitutes Available on the Swedish Market. | Nutrients | 2022 | 36235566 | PubTator, text mining | PubMed |
| Enhanced Uptake and Phototoxicity of C60@albumin Hybrids by Folate Bioconjugation. | Nanomaterials (Basel) | 2022 | 36234629 | PubTator, text mining | PubMed |
| A Previously Unrecognized Molecular Landscape of Lynch Syndrome in the Mexican Population. | Int J Mol Sci | 2022 | 36232851 | PubTator, text mining | PubMed |
| Genomic Landscape of Mixed-Phenotype Acute Leukemia. | Int J Mol Sci | 2022 | 36232559 | PubTator, text mining | PubMed |
| PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures. | Cancers (Basel) | 2022 | 36230674 | PubTator, text mining | PubMed |
| Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers. | Cancers (Basel) | 2022 | 36230652 | PubTator, text mining | PubMed |
| The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers. | Cancers (Basel) | 2022 | 36230545 | PubTator, text mining | PubMed |
| Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care. | Front Pediatr | 2022 | 36225340 | PubTator, text mining | PubMed |
| The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy. | Cell Death Discov | 2022 | 36220835 | PubTator, text mining | PubMed |
| Pan-cancer analysis of LncRNA XIST and its potential mechanisms in human cancers. | Heliyon | 2022 | 36212008 | PubTator, text mining | PubMed |
| RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS. | Blood Adv | 2022 | 36206200 | PubTator, text mining | PubMed |
| Tailored Skin Flaps for Hand Reconstruction. | Plast Reconstr Surg Glob Open | 2022 | 36203738 | PubTator, text mining | PubMed |
Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations. | Ther Adv Med Oncol | 2022 | 36199621 | PubTator, text mining | PubMed |
| Rare-variant collapsing analyses identified risk genes for neonatal acute respiratory distress syndrome. | Comput Struct Biotechnol J | 2022 | 36187926 | PubTator, text mining | PubMed |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=37